Ainnova Tech
Health tech based in Houston, Texas and with offices in Costa Rica and Mexico. Its purpose is to create the future of early disease detection in an accessible way, using its AI platforms with the retina as a new vital sign, for the early detection of diabetic retinopathy, cardiovascular risk, early Alzheimer's and now its new retinal imaging device that is a game changer in the market. The company has been recognized by Forbes as one of the 30 promising companies of 2024 in Latam, recognized as the best health tech startup at the Florida International Medical Expo and nominated for innovative company of the year by the Arab health 2024 and Dubai. It also has Boston Scientific as a partner and ally in its new spin-off company for cardiovascular risk detection in retinal images.
Ainnova Tech
Health tech based in Houston, Texas and with offices in Costa Rica and Mexico. Its purpose is to create the future of early disease detection in an accessible way, using its AI platforms with the retina as a new vital sign, for the early detection of diabetic retinopathy, cardiovascular risk, early Alzheimer's and now its new retinal imaging device that is a game changer in the market. The company has been recognized by Forbes as one of the 30 promising companies of 2024 in Latam, recognized as the best health tech startup at the Florida International Medical Expo and nominated for innovative company of the year by the Arab health 2024 and Dubai. It also has Boston Scientific as a partner and ally in its new spin-off company for cardiovascular risk detection in retinal images.